Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/12762
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Mitchell, Paul L R | en |
dc.date.accessioned | 2015-05-16T02:30:02Z | |
dc.date.available | 2015-05-16T02:30:02Z | |
dc.date.issued | 2015-04-01 | en |
dc.identifier.citation | Asia-pacific Journal of Clinical Oncology; 11 Suppl 1(): 1 | en |
dc.identifier.govdoc | 25913638 | en |
dc.identifier.other | PUBMED | en |
dc.identifier.uri | https://ahro.austin.org.au/austinjspui/handle/1/12762 | en |
dc.language.iso | en | en |
dc.title | Evolving treatment paradigms in lung cancer: role of immuno-oncology. | en |
dc.type | Journal Article | en |
dc.identifier.journaltitle | Asia-Pacific journal of clinical oncology | en |
dc.identifier.affiliation | Medical Oncology Unit, Olivia Newton-John Cancer and Wellness Centre, Austin Health, Heidelberg, Victoria, Australia | en |
dc.identifier.doi | 10.1111/ajco.12360 | en |
dc.description.pages | 1 | en |
dc.relation.url | https://pubmed.ncbi.nlm.nih.gov/25913638 | en |
dc.type.austin | Journal Article | en |
local.name.researcher | Mitchell, Paul L R | |
item.openairetype | Journal Article | - |
item.cerifentitytype | Publications | - |
item.grantfulltext | none | - |
item.fulltext | No Fulltext | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.languageiso639-1 | en | - |
crisitem.author.dept | Medical Oncology | - |
crisitem.author.dept | Olivia Newton-John Cancer Wellness and Research Centre | - |
Appears in Collections: | Journal articles |
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.